Table 3.
1. To enable detection of MRONJ as early as possible, nurses can proactively ask the patient about the possible signs and symptoms of MRONJ (Fig. 1), and if there is any doubt, nurses should discuss their concerns with the treating physician, dentist, and general practitioner. 2. To assess risk factors for MRONJ, nurses can ask the patient questions based on the known risk factors for MRONJ and determine whether the patient is at low or increased risk of MRONJ (Online resource: Supplementary data 1/2). 3. To ensure patient compliance with MRONJ preventative measures and any subsequent treatment, nurses can provide the patient with clear explanations, information, and education on MRONJ risks and the preventative steps that can be taken to reduce this risk (Figs. 2 and 3). 4. To put the risk of MRONJ into context with the patient’s other health issues, nurses can educate the patient on how infrequent MRONJ is relative to the benefits of BMA treatment. 5. To ensure appropriate clinical management of MRONJ, nurses can encourage communication between the patient, the physician, and the dentist (Fig. 3). |
BMA, bone-modifying agent; MRONJ, medication-related osteonecrosis of the jaw